Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Efficacy of Hepatitis B Vaccination in Under Five-Year-Old Children in Iran: A Systematic Review and Meta-Analysis Study Publisher



Najafi F1 ; Sayehmiri K2 ; Najafi R3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Internal-Surgical Nursing, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Health Faculty, Biostatistics Department, Ilam University of Medical Sciences, Ilam, Iran
  3. 3. Pediatric Endocrinology Department, Ilam University of Medical Sciences, Ilam, Iran

Source: Hepatitis Monthly Published:2018


Abstract

Context: Hepatitis B viral infection, specially in children, is an unsolved global health issue. National and international vaccination programs, as the main means to prevent this infection, have been operating for years. This meta-analysis study was launched to investigate the vaccination efficacy in under five-year-old children in Iran. Evidence Acquisition: In this research, all national databases including, SID, Magiran, Iran medex, Iran doc, and Medlib, as well as international databases, including PubMed, Medline, and ISI were searched for published articles associated with evaluation of seroconversion rates after hepatitis-B vaccination in Iranian children. The search was performed in the Persian and/or English language and in under five-year-old children in Iran. The variance of each study was calculated using the binomial distribution formula. The results of studies were combined using random-effects meta-analysis model. Data were analyzed using STATA version 12. Results: In the present research, 11 studies, performed from 2000 to 2017, were investigated. The number of samples in these 11 studies were 3063 children (1592 males and 1471 females). In the studies, the efficacy range of the hepatitis-B vaccine in under fiveyear-old children in Iran was 89% (95% CI: 86% 93%) with high heterogeneity (P value for heterogeneity was 0.001, I2 = 92.9). Range of efficacy for males and females was 85% (95% CI: 78 to 91) and 88% (95% CI: 83 to 93), respectively. Conclusions: The hepatitis B virus (HBV) vaccination program in Iran seems to be highly effective although some questions, such as the effect of gender on responsiveness to vaccine and heterogeneity of different data, remain unclear. © 2018, Hepatitis Monthly.
Related Docs
1. Prevalence of National Responsiveness to Hbv Vaccine After 22 Years of Iranian Expanded Program on Immunization (Epi): A Systematic Review and Meta-Analysis Study, Hepatitis Monthly (2015)
2. Measurement of Serum Hepatitis B Surface Antibody Levels in Iranian Autistic Children and Evaluation of Immunological Memory After Booster Dose Injection in Comparison With Controls, Journal of Medical Virology (2019)
3. The Association of the Vitamin D Status With the Persistence of Anti-Hbs Antibody at 20 Years After Primary Vaccination With Recombinant Hepatitis B Vaccine in Infancy, Clinics and Research in Hepatology and Gastroenterology (2017)
4. Identification of Occult Hepatitis B Virus (Hbv) Infection and Viral Antigens in Healthcare Workers Who Presented Low to Moderate Levels of Anti-Hbs After Hbv Vaccination, GERMS (2015)
5. Human Leukocyte Antigens Influence the Antibody Response to Hepatitis B Vaccine, Iranian Journal of Allergy# Asthma and Immunology (2015)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Jazayeri (3)
Fazel Shokri (2)